Press release
Rising Cancer Prevalence Fueling The Growth Due To Increasing Demand For Targeted Immunotherapies Emerges as a Core Driver of the Natural Killer (NK) Cell Therapeutics Market in 2025
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.What Is the Expected CAGR for the Natural Killer (NK) Cell Therapeutics Market Through 2025?
The market size for natural killer (NK) cell therapeutics has expanded swiftly in the last few years. Projected to increase from $3.52 billion in 2024 to $3.93 billion in 2025, with a compound annual growth rate (CAGR) of 11.6%. This substantial growth in the previous period is attributable to the surge in cancer cases, enhanced R&D funding, increased understanding of immunotherapy, growth in strategic partnerships within the industry, amplified regulatory backing, and advancements in cell expansion technologies.
What's the Projected Size of the Global Natural Killer (NK) Cell Therapeutics Market by 2029?
The market size for natural killer (NK) cell therapeutics is predicted to witness substantial expansion in the approaching years, swelling to $6.17 billion in 2029 with a compound annual growth rate (CAGR) of 12.0%. This projected growth during the forecast period can be ascribed to factors such as the increase in clinical trials, escalated investment in immunotherapy research and development, wider usage in solid tumors, strategic partnerships, regulatory backing for cell therapies, and the escalating demand from patients for customized cancer treatments. Key trends anticipated during the forecast period encompass breakthroughs in genetic engineering, advancements in CAR-NK therapies, evolution of cell expansion methods, novel developments in clinical trial activities, production of ready-to-use NK cell products, and progress in solid tumor treatment methods.
View the full report here:
https://www.thebusinessresearchcompany.com/report/natural-killer-nk-cell-therapeutics-global-market-report
Top Growth Drivers in the Natural Killer (NK) Cell Therapeutics Industry: What's Accelerating the Market?
The escalating rates of cancer are likely to stimulate the expansion of the natural killer (NK) cell therapeutics market. Cancer is characterized by the uncontrolled proliferation of atypical cells, which invade surrounding tissues and metastasize to other parts of the body. This deregulation of normal cell activity results in tumor formation and bodily impairment. Factors such as environmental exposure to pollutants, tobacco smoke, and chemicals can harm the deoxyribonucleic acid (DNA) and interfere with cell function, thereby heightening the risk of cancer. NK cell therapeutics aid in cancer treatment by targeting and eliminating tumor cells without any prior sensitization. For instance, the American Cancer Society, a US-based non-profit organization, reported in April 2024 that 20 million new cancer cases were identified and 9.7 million individuals succumbed to the disease worldwide in 2022. By 2050, solely due to anticipated population growth, the count of cancer cases is expected to escalate to 35 million. Consequently, the increasing incidence of cancer is promoting the growth of the natural killer (NK) cell therapeutics market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24328&type=smp
Which Emerging Trends Are Transforming the Natural Killer (NK) Cell Therapeutics Market in 2025?
Prominent businesses in the natural killer (NK) cell therapeutics market are concentrating on innovations such as devising scalable iPSC-based NK cell manufacturing infrastructures, which will facilitate cost-efficient, readily available NK cell treatments. These infrastructures employ induced pluripotent stem cells (iPSCs) to produce NK cells in a standardized, feeder-free, confined bioreactor setting, guaranteeing high yields and regulatory complaisance. For example, in April 2025, the Belgium-based biotechnology research firm, Cellistic, introduced the Echo-NK platform, an iPSC-centric manufacturing solution for NK cell therapies. The platform provides scalable production of NK cells aimed at targeting blood cancers, solid tumors, and autoimmune diseases, executing all critical expansion processes in confined bioreactor environments within Cellistic's EMA-certified GMP establishment. By incorporating Cellistic's Pulse cell line development skills and proprietary STAR-CRISPR technology, the Echo-NK platform expedites the timelines for producing stable iPSC cell lines with particular gene edits, delivering a commercially sustainable solution for readily available NK cell therapies.
What Are the Main Segments in the Natural Killer (NK) Cell Therapeutics Market?
The natural killer (nk) cell therapeutics market covered in this report is segmented -
1) By Therapeutics: Natural Killer (NK) Cell Directed Antibodies, Natural Killer (NK) Cell Therapies
2) By Application: Immunoproliferative Disorders, Gastrointestinal Diseases, Cancer, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Direct Tender, Other Distribution Channels
4) By End User: Research And Academic Institutes, Hospitals, Specialty Clinics
Subsegments:
1) By Natural Killer (NK) Cell Directed Antibodies: Monoclonal Antibodies (mAbs), Bispecific Antibodies (BsAbs), Antibody-Drug Conjugates (ADCs)
2) By Natural Killer (NK) Cell Therapies: Autologous NK Cell Therapies, Allogeneic NK Cell Therapies, Chimeric Antigen Receptor (CAR)-NK Cell Therapies
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24328&type=smp
Which Top Companies are Driving Growth in the Natural Killer (NK) Cell Therapeutics Market?
Major companies operating in the natural killer (NK) cell therapeutics market are Sanofi S.A., Thermo Fisher Scientific, Lonza AG, Catalent, Kite Pharma, Fate Therapeutics, Artiva Biotherapeutics, Nkarta, Inc, Celularity Inc., NKGen Biotech, Dragonfly Therapeutics, Cytovia Therapeutics, Glycostem Therapeutics, Gamida Cell, ONK Therapeutics, Wugen Inc., AGC Biologics, CytoImmune Therapeutics, XNK Therapeutics, Indapta Therapeutics, Neukio Biotherapeutics, Senti Biosciences, WuXi Advanced Therapies, Kiadis Pharma
Which Regions Will Dominate the Natural Killer (NK) Cell Therapeutics Market Through 2029?
North America was the largest region in the natural killer (NK) cell therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the natural killer (NK) cell therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24328
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Cancer Prevalence Fueling The Growth Due To Increasing Demand For Targeted Immunotherapies Emerges as a Core Driver of the Natural Killer (NK) Cell Therapeutics Market in 2025 here
News-ID: 4184111 • Views: …
More Releases from The Business Research Company
Nano Antibodies Market Overview: Major Segments, Strategic Developments, and Lea …
The nano antibodies market is gaining significant attention due to its promising applications in precision medicine and targeted therapies. With rapid advancements in biotechnology and increasing research efforts, this market is poised for considerable expansion in the coming years. Let's explore the current market valuation, key drivers, leading companies, and emerging trends shaping this dynamic sector.
Projected Growth and Market Size of the Nano Antibodies Market
The nano antibodies market is anticipated…
Emerging Sub-Segments Transforming the Mitotic Spindle Organizing Protein 2B (MZ …
Understanding the growth potential of niche biotechnology markets reveals exciting opportunities for innovation and investment. One such area gaining attention is the mitotic spindle organizing protein 2B (MZT2B) antibody market, which is poised for remarkable expansion due to advances in medical research and technology. Let's explore the current landscape, key players, market segments, and factors driving this market forward.
Projected Growth Trajectory of the Mitotic Spindle Organizing Protein 2B (MZT2B) Antibody…
Top Players and Competitive Dynamics in the Menopause Supplement Market
The menopause supplement market is set for significant expansion in the coming years, driven by evolving healthcare demands and growing awareness of women's wellness. As more individuals seek tailored health solutions, the market is responding with innovative products and services designed to support women during menopause and beyond. Below, we explore the market size, influential players, and emerging trends shaping this industry's future.
Expected Growth Trajectory of the Menopause Supplement Market
The…
In-Depth Examination of Segments, Industry Developments, and Key Players in the …
The market for liquid carbon dioxide storage tanks is set for strong expansion in the coming years, supported by rising sustainability priorities and steady technological advancements across multiple industries. A closer look at the market size, major players, evolving trends, and detailed segmentation provides a clear understanding of the current dynamics and future potential.
Projected Growth and Market Size of Liquid Carbon Dioxide Storage Tanks
The liquid carbon dioxide storage tanks market…
More Releases for Cell
Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting.
Download Full PDF Sample Copy…
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
